The role of CD11c expression in the diagnosis of mantle cell lymphoma

American Journal of Clinical Pathology

Volumn 134, Issue 2, 2010, Pages 271-277

  Kraus, Teresa S ^a   Sillings, Christine N ^a   Saxe, Debra F ^a   Li, Shiyong ^a   Jaye, David L ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

CD11c; Chronic lymphocytic leukemia; Flow cytometry; Mantle cell lymphoma

Indexed keywords

CD5 ANTIGEN; CYCLIN D1; GLYCOPROTEIN P 15095;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; FLOW CYTOMETRY IMMUNOPHENOTYPING; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; KARYOTYPING; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11C; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 77955596989     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPOGCI3DAXVUMI     Document Type: Article

References (33)

1. Zhao XF. Pitfalls in diagnostic hematopathology: part I. Int J Clin Exp Pathol. 2009;2:11-20.
2. Ho AK, Hill S, Preobrazhensky SN, et al. Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias. Am J Clin Pathol. 2009;131:27-32.
3. Morice WG, Kurtin PJ, Hodnefield JM, et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc. 2008;83:776-785.
4. Kelemen K, Peterson LC, Helenowski I, et al. CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol. 2008;130:166-177.
5. Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res. 2009;33:1212-1216.
6. Bertoni F, Rinaldi A, Zucca E, et al. Update on the molecular biology of mantle cell lymphoma. Hematol Oncol. 2006;24:22-27.
7. Wohlschlaeger C, Lange K, Merz H, et al. Aberrant immunophenotypes of mantle cell lymphomas. Leuk Lymphoma. 2003;44:269-273.
8. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
9. Cro L, Guffanti A, Colombi M, et al. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia. 2003;17:125-132.
10. Craig FE. Flow cytometric evaluation of B-cell lymphoid neoplasms. Clin Lab Med. 2007;27:487-512, vi.
11. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol. 1996;105:451-457.
12. Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol. 2003;120:760-766.
13. Domingo A, Gonzalez-Barca E, Castellsague X, et al. Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukemia: relationship with clinicoprognostic features. Leuk Res. 1997;21:67-73.
14. Pinto A, Carbone A, Gloghini A, et al. Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders. Cancer. 1993;72:894-904.
15. Shaffer L, Tommerup N, eds. ISCN 2005: An International System for Human Cytogenetic Nomenclature (2005). Basel, Switzerland: S Karger; 2005.
16. Gorczyca W. Flow Cytometry in Neoplastic Hematology: Morphologic- Immunophenotypic Correlation. London, England: Taylor & Francis; 2006.
17. Borowitz MJ, Bray R, Gascoyne R, et al. US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry. 1997;30:236-244.
18. Jaye DL, Geigerman CM, Herling M, et al. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol. 2006;19:1555-1562.
19. Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood. 2009;114:1469-1476.
20. Tworek JA, Singleton TP, Schnitzer B, et al. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol. 1998;110:582-589.
21. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3:185-197.
22. Baldini L, Cro L, Calori R, et al. Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. Blood. 1992;79:2688-2693.
23. Olejniczak SH, Stewart CC, Donohue K, et al. A quantitative exploration of surface antigen expression in common B-cell malignancies using flow cytometry. Immunol Invest. 2006;35:93-114.
24. Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol. 1999;36:178-197.
25. Argatoff LH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.
26. Angelopoulou MK, Siakantariz MP, Vassilakopoulos TP, et al. The splenic form of mantle cell lymphoma. Eur J Haematol. 2002;68:12-21.
27. Takeshita M, Masuda Y, Sumiyoshi Y, et al. Clinicopathologic, enzyme and histochemical studies of centrocytic (mantle cell) lymphoma: comparison with other types of low-grade B cell lymphoma based on the updated Kiel classification. Acta Pathol Jpn. 1993;43:244-252.
28. Matos DM, Rizzatti EG, Garcia AB, et al. Adhesion molecule profiles of B-cell non-Hodgkin's lymphomas in the leukemic phase. Braz J Med Biol Res. 2006;39:1349-1355.
29. Weisenburger DD, Nathwani BN, Diamond LW, et al. Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer. 1981;48:1415-1425.
30. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 2005;106:4315-4321.
31. Stefancikova L, Moulis M, Fabian P, et al. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected. J Clin Pathol. 2009;62:948-950.
32. Kjeldsberg CR. Practical Diagnosis of Hematologic Disorders. 4th ed. Chicago, IL: ASCP Press; 2006.
33. Batstone P, Forsyth L, Goodlad JR. Cytogenetic evidence for the origin of neoplastic cells in CD5-positive marginal zone B-cell lymphoma. Hum Pathol. 2003;34:1065-1067.